De Becker Farmaceutica SRL
De Becker Farmaceutica reported total assets of €1.01m at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Jun 2026).
By total assets for 2025, De Becker Farmaceutica ranks in the top half of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of De Becker Farmaceutica shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
De Becker Farmaceutica's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jul 2025
De Becker Farmaceutica's financial analysis
- Solvency14.6%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of De Becker Farmaceutica
De Becker Farmaceutica's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1006.778.737
- VAT number
- BE1006778737
- Peppol
- Registered · 0208:1006778737 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Mar 2024
- Registered office
- 2660 Antwerp
- Latest accounts
- 2025 · filed on 12 Jun 2026
- Activity
- Activities of holding companies (NACE 64210)
De Becker Farmaceutica (SRL) has been based in Antwerp since 2024, active in: activities of holding companies. For 2025, it reports a net profit of 105,794 € and equity of 147,454 €; its revenue is not published. Its solvency stands at 14.6%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to De Becker Farmaceutica
Companies in the same business, of comparable size and area, outside its group.
- 1M Activities of holding companies Schelle · balance sheet €1.01m
- Gert Schepers Activities of holding companies Laakdal · balance sheet €1.01m
- Wine On Wheels Activities of holding companies Retie · balance sheet €1.00m
- WK Vandecasteele Management Activities of holding companies Lendelede · balance sheet €1.01m
- Volailles Wenkin et Fils Activities of holding companies Bertrix · balance sheet €1.01m
- Groep Dhaenens Activities of holding companies Kaprijke · balance sheet €1.01m
- Poltermann Activities of holding companies Ghent · balance sheet €1.00m
- The HNC Activities of holding companies Antwerp · balance sheet €1.01m
Frequently asked questions about De Becker Farmaceutica
What is the revenue of De Becker Farmaceutica?
De Becker Farmaceutica files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of De Becker Farmaceutica?
In Belgium, the VAT number is the company number prefixed with BE: BE1006778737 for De Becker Farmaceutica, if the company is VAT-registered. Its company number (CBE) is 1006.778.737.
Where is the registered office of De Becker Farmaceutica?
According to the CBE register, the registered office of De Becker Farmaceutica is in 2660 Antwerp.
What is the equity of De Becker Farmaceutica?
At the close of the 2025 financial year, the equity of De Becker Farmaceutica amounts to 147,454 €, a solvency of 14.6% of total assets.
Who manages De Becker Farmaceutica?
The register lists 2 active mandates at De Becker Farmaceutica. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is De Becker Farmaceutica within its sector?
By total assets for 2025, De Becker Farmaceutica ranks in the top half of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year.
The full file of De Becker Farmaceutica
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →